SCHEMBL3337408

SCHEMBL3337408

CCC1(CC)[CH]CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL461958 0.77
SCHEMBL27910610 0.70
SCHEMBL5260305 0.69 OPRM1 (0.33)
SCHEMBL4780225 0.66
SCHEMBL27972302 0.65
SCHEMBL6681595 0.64
SCHEMBL7159584 0.63
SCHEMBL8731627 0.63
SCHEMBL193409 0.63
SCHEMBL11346522 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108101855-A A kind of Preparation method and use of the amino acid esters compound of -6- of piperidyl containing 4- methylpyrimidine heterocycles 贵州理工学院 2018-06-01 CN claimed
US-20100152127-A1 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2010-06-17 US claimed
EP-1740587-A4 SELECTIVE ANTAGONISTS OF A-2A- ADENOSINE RECEPTORS ADENOSINE THERAPEUTICS LLC (US) 2009-07-15 EP claimed
US-20090170803-A1 ADJUNCTIVE TREATMENT OF BIOLOGICAL DISEASES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-07-02 US claimed
US-7217702-B2 Selective antagonists of A2A adenosine receptors ADENOSINE THERAPEUTICS, LLC (US) 2007-05-15 US claimed
EP-1740587-A2 SELECTIVE ANTAGONISTS OF A-2A- ADENOSINE RECEPTORS Adenosine Therapeutics, LLC (US) 2007-01-10 EP claimed
US-20050282831-A1 Selective antagonists of A2A adenosine receptors ADENOSINE THERAPEUTICS, LLC 2005-12-22 US claimed
WO-2005097140-A2 SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS ADENOSINE THERAPEUTICS, LLC (US) 2005-10-20 WO claimed
CN-108033916-B Preparation of amino acid ester compound and application of amino acid ester compound in preventing and treating tobacco diseases 贵州理工学院 2021-02-26 CN disclosed
CN-108101855-B Preparation method and application of amino acid ester compound containing 4-piperidyl-6-methylpyrimidine heterocycle 贵州理工学院 2021-01-01 CN disclosed
CN-108101855-A A kind of Preparation method and use of the amino acid esters compound of -6- of piperidyl containing 4- methylpyrimidine heterocycles 贵州理工学院 2018-06-01 CN disclosed
CN-102480967-A Compounds and methods for treating influenza ROMARK LAB LC 2012-05-30 CN disclosed
EP-1740587-A4 SELECTIVE ANTAGONISTS OF A-2A- ADENOSINE RECEPTORS ADENOSINE THERAPEUTICS LLC (US) 2009-07-15 EP disclosed
US-20080176858-A1 SELECTIVE ANTAGONISTS OF A2A ADENOSINE RECEPTORS ADENOSINE THERAPEUTICS, LLC (US) 2008-07-24 US disclosed
EP-1476452-A2 ACYL- AND BISACYLPHOSPHINE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2004-11-17 EP disclosed
WO-2003068785-A1 MONO- AND BIACYLPHOSPHINE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2003-08-21 WO disclosed
WO-2003068783-A1 ALKOXYLATED ACYL- AND BISACYLPHOSPHINE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2003-08-21 WO disclosed
WO-2003068784-A2 ACYL- AND BISACYLPHOSPHINE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2003-08-21 WO disclosed
EP-0069811-B1 BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF PFIZER INC. (US) 1984-10-24 EP disclosed
US-4399163-A ARTIFICIAL SWEETENERS PFIZER INC. (US) 1983-08-16 US disclosed